COMMUNIQUÉS West-GlobeNewswire

CRISPR Therapeutics to Present at Upcoming Investor Conferences
01/10/2019
ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Fulcrum Therapeutics Announces Multiple Presentations of Losmapimod Data at World Muscle Society Meeting
01/10/2019
Oral presentation to highlight Phase 1 data on safety, tolerability and target engagement of losmapimod in treatment of FSHD Company also announces updated preclinical data on FTX-6058 for potential treatment of sickle [...]
Microbix Presenting at StableView TECH19 Conference
01/10/2019
Meetings with Growth-Oriented Investors, October 3, 2019 MISSISSAUGA, Ontario, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix ® ), an innovator of clinical diagnostic materials and [...]
Constellation Pharmaceuticals Announces $65 Million Private Placement with New and Existing Investors
01/10/2019
CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Amicus Therapeutics to Present at Upcoming Medical and Investor Conferences in October 2019
01/10/2019
CRANBURY, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced upcoming presentations at the following medical and investor conferences in October. Upcoming Medical Conferences: An [...]
Scilex Announces New Medicaid Agreements with CA & FL
01/10/2019
PALO ALTO, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Scilex Holding Company (Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE), is excited to announce that its subsidiary, Scilex [...]
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
01/10/2019
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity. Amsterdam, The Netherlands – 1st October 2019 Esperite N.V. (the Group) confirmed on 22nd February 2019 the intentions [...]
TLC Announces Initiation of Phase III Pivotal Clinical Trial of TLC599 for the Treatment of Osteoarthritis Knee Pain
01/10/2019
- Phase II results showed statistically significant pain relief through 24 weeks - Phase III to evaluate efficacy of single and repeated doses up to 52 weeks SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 01, 2019 [...]
Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
01/10/2019
- Oerth Bio to utilize Arvinas’ PROTAC® technology to develop innovative new agricultural products to improve crop yields - John Dombrosky Announced as CEO of Oerth Bio - Transaction had been formally closed on July 15 [...]
Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon
01/10/2019
October 1, 2019 Primary safety analysis of Stellarex drug-coated balloon (DCB) three-year data, comprising the largest published, pooled set of randomized controlled trial (RCT) data for a single paclitaxel-based device [...]
Integrated Cannabis’ Ganja Gold takes Delivery of Fully Automated Proprietary Pre-Roll Manufacturing Machine
01/10/2019
VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ” or the “ Company ”), a multi-state brand operator in California and [...]
iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest
01/10/2019
Company to exhibit ProFound AI for 2D and 3D Mammography in Europe NASHUA, N.H. and BUDAPEST, Hungary, Oct. 01, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative [...]
Eurobio Scientific joins the Enternext PEA PME 150 index
01/10/2019
Eurobio Scientific joins the Enternext PEA PME 150 index Paris, October 1st 2019 – 8:00 am Eurobio Scientific ( FR0013240934, ALERS), the leading French group in the field of in vitro medical diagnostics and life [...]
Eurobio Scientific entre dans l’indice Enternext PEA PME 150
01/10/2019
Eurobio Scientific entre dans l’indice Enternext PEA PME 150 Paris, le 1 er octobre 2019 – 8h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de [...]
Innate Pharma presents early clinical data on IPH5401 and monalizumab at the ESMO 2019 congress
01/10/2019
IPH5401 dose-escalation study in combination with durvalumab in advanced solid tumors, STELLAR-001, shows manageable safety profile Initiation of two expansion cohorts in non-small cell lung cancer (NSCLC) with [...]
INNATE PHARMA PRÉSENTE DES RESULTATS CLINIQUES PRELIMINAIRES SUR IPH5401 ET MONALIZUMAB AU CONGRÈS DE L’ESMO 2019
01/10/2019
Profil de sécurité gérable de la combinaison d’IPH5401 avec durvalumab dans l’étude en escalade de dose STELLAR-001 dans des tumeurs solides avancées Deux extensions de cohorte ont démarré : dans le cancer du poumon non [...]
IBA receives down payment for Proteus®PLUS contract in Shenzhen, China
01/10/2019
Seven proton therapy rooms already sold by IBA this year Louvain-la-Neuve, Belgium, 1 October, 2019 - IBA ( Ion Beam Applications SA ), the world’s leading provider of proton therapy solutions for the treatment of [...]
IBA reçoit l’acompte du contrat pour un Proteus®PLUS à Shenzhen en Chine
01/10/2019
IBA a déjà signé des contrats pour sept salles de protonthérapie cette année Louvain-La-Neuve, Belgique, 1 er octobre 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de [...]
FibroGen Receives One of China Pharmaceutical Industry’s Highest Awards for Clinical Innovation for Roxadustat
01/10/2019
SAN FRANCISCO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that roxadustat received the 2019 Dushu Lake Prize 独墅湖杯in China for “On-Market Innovative Drug with Highest Clinical Value [...]

Pages